MorphoSys AG Skyrocketed
Mon, Feb 05, 2024 at 07:32 PM
MorphoSys AG (MOR:NASDAQ) soared at $17.27, representing a gain of 56%. On Mon, Feb 05, 2024, MOR:NASDAQ touched a New 2-Week High of $17.27. The stock appeared on our News Catalysts scanner on Mon, Feb 05, 2024 at 06:40 PM in the 'AGREEMENT' category. From Mon, Jan 22, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
About MorphoSys AG (MOR:NASDAQ)
MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.
Top 10 Gainers:
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 96.36%
- 4D Molecular Therapeutics Inc. (FDMT:NASDAQ), 84.62%
- USD Partners LP (USDP:NYSE), 72.47%
- MorphoSys AG (MOR:NASDAQ), 56.01%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 52.57%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 45.99%
- Selina Hospitality PLC (SLNA:NASDAQ), 43.79%
- Warrantee Inc. (WRNT:NASDAQ), 40.64%
- Jianpu Technology Inc. (JT:NYSE), 34.67%
- Adverum Biotechnologies, Inc. (ADVM:NASDAQ), 34.51%